The first shipment of the new anti-tuberculosis drug to go to Israel was sent by air freight from Idlewild Airport today by Hadassah to its hospitals in Israel.
Mrs. Rebecca Shulman, national chairman of Hadassah’s Medical Organization Committee, said that 5,000 tablets of “Ditubin” were shipped in answer to a request by Dr. Kalman J. Mann, Hadassah’s medical director general in Israel. Dr. Mann had asked for the drug in order that Hadassah’s tuberculosis hospitals in Israel could “undertake a series of clinically controlled experiments to determine its effect in the treatment of tuberculosis.”
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
